Activist Biglari Capital Files Definitive Proxy to Oust Chairman Goebel, Oppose Key Proposals
JACK sits 49% above its 52-week low of $13.993 on light trading volume (0.4× avg).
Summary
Activist investor Biglari Capital, holding nearly 10% of Jack in the Box, has filed its definitive proxy statement, urging shareholders to vote against Chairman David Goebel's re-election and oppose several key management proposals, citing years of shareholder value destruction and strategic missteps.
Key Events · Ownership and Investor Activity · JACK
-
Proxy Contest Finalized
Activist investor Biglari Capital filed its definitive proxy statement for the upcoming Annual Meeting on February 27, 2026, following a series of preliminary filings from both the activist and the company.
-
Targeting Chairman Goebel
Biglari urges shareholders to vote "AGAINST" the re-election of Chairman David Goebel, citing his responsibility for "years of shareholder value destruction" and strategic missteps.
-
Opposing Key Management Proposals
Biglari recommends voting "AGAINST" the company's Say on Pay proposal, the amendment to increase shares in the 2023 Omnibus Incentive Plan, and the ratification of the Stockholder Protection Rights Agreement (poison pill).
-
Citing Underperformance & Del Taco Loss
The activist highlights Jack in the Box's significant underperformance against peers and the Russell 3000, specifically pointing to the nearly 80% loss on the Del Taco acquisition as evidence of poor capital allocation.
Analysis · JACK · Trade & Services
This definitive proxy statement from Biglari Capital marks a critical escalation in the ongoing proxy contest at Jack in the Box. Biglari, a significant shareholder, is directly challenging the re-election of Chairman David Goebel, attributing years of underperformance and strategic failures, including the substantial loss from the Del Taco acquisition, to his leadership. Furthermore, Biglari is campaigning against the company's executive compensation, a proposed increase in the equity incentive plan, and the ratification of a "poison pill" defense, arguing these measures entrench the board and harm shareholder value. The upcoming annual meeting on February 27, 2026, will be a pivotal moment for the company's governance and strategic direction, with shareholders now having the final arguments from the activist to consider.
At the time of this filing, JACK was trading at $20.81 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $397.5M. The 52-week trading range was $13.99 to $44.15. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.